Cite Filings / IBO / 0001641172-25-002820
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

IMPACT BIOMEDICAL INC. · Filed 2025-04-04 · Acc 0001641172-25-002820

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-04-07 4 10% owner sold 890,800 shares at $0.95 ($845,013)
  • 2025-04-07 4 Director sold 351,555 shares at $0.50 ($174,020)
  • 2025-04-04 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-04-04 4 Director sold 1,689,693 shares at an average $0.66 ($1,122,920)
  • 2025-04-03 8-K Material agreement
  • 2025-04-02 SCHEDULE 13D Beneficial Ownership Report
  • 2025-04-02 4 Director sold 2,526,918 shares at an average $1.15 ($2,912,821)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…